Filter News
Area of Research
News Topics
- (-) Composites (1)
- (-) Fusion (1)
- (-) Isotopes (3)
- (-) Security (1)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (2)
- Artificial Intelligence (2)
- Bioenergy (7)
- Biology (1)
- Biomedical (2)
- Biotechnology (1)
- Chemical Sciences (2)
- Climate Change (2)
- Computer Science (7)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (4)
- Environment (6)
- Exascale Computing (1)
- High-Performance Computing (1)
- Machine Learning (2)
- Materials (2)
- Materials Science (3)
- Microscopy (1)
- Molten Salt (1)
- Nanotechnology (4)
- Neutron Science (3)
- Nuclear Energy (6)
- Physics (1)
- Polymers (2)
- Quantum Science (1)
- Summit (2)
- Sustainable Energy (9)
- Transformational Challenge Reactor (2)
- Transportation (3)
Media Contacts
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
ORNL and Department of Energy officials dedicated the launch of two clean energy research initiatives that focus on the recycling and recovery of advanced manufacturing materials and on connected and
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Brixon, Inc., has exclusively licensed a multiparameter sensor technology from the Department of Energy’s Oak Ridge National Laboratory. The integrated platform uses various sensors that measure physical and environmental parameters and respond to standard security applications.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.